FHIT gene therapy prevents tumor development in Fhit-deficient mice

被引：138

作者：

Dumon, KR ^{[1
]}

Ishii, H ^{[1
]}

Fong, LYY ^{[1
]}

Zanesi, N ^{[1
]}

Fidanza, V ^{[1
]}

Mancini, R ^{[1
]}

Vecchione, A ^{[1
]}

Baffa, R ^{[1
]}

Trapasso, F ^{[1
]}

During, MJ ^{[1
]}

Huebner, K ^{[1
]}

Croce, CM ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2001年 / 98卷 / 06期

关键词：

D O I：

10.1073/pnas.061020098

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The tumor suppressor gene FHIT spans a common fragile site and is highly susceptible to environmental carcinogens. FHIT inactivation and loss of expression is found in a large fraction of premaligant and malignant lesions. In this study, we were able to inhibit tumor development by oral gene transfer, using adenoviral or adenoassociated viral vectors expressing the human FHIT gene, in heterozygous Fhit(+/-) knockout mice, that are prone to tumor development after carcinogen exposure. We therefore suggest that FHIT gene therapy could be a novel clinical approach not only in treatment of early stages of cancer, but also in prevention of human cancer.

引用

页码：3346 / 3351

页数：6

共 32 条

[1] Berns K I, 1979, Adv Virus Res, V25, P407, DOI 10.1016/S0065-3527(08)60574-6
[2] RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA
BLOT, WJ
DEVESA, SS
KNELLER, RW
FRAUMENI, JF
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10): : 1287 - 1289
[3] NUCLEAR PATTERNS OF CYCLIN (PCNA) ANTIGEN DISTRIBUTION SUBDIVIDE S-PHASE IN CULTURED-CELLS - SOME APPLICATIONS OF PCNA ANTIBODIES
CELIS, JE
MADSEN, P
NIELSEN, S
CELIS, A
[J]. LEUKEMIA RESEARCH, 1986, 10 (03) : 237 - 249
[4] Role of FHIT in human cancer
Croce, CM
Sozzi, G
Huebner, K
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1618 - 1624
[5] An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
During, MJ
Symes, CW
Lawlor, PA
Lin, J
Dunning, J
Fitzsimons, HL
Poulsen, D
Leone, P
Xu, RA
Dicker, BL
Lipski, J
Young, D
[J]. SCIENCE, 2000, 287 (5457) : 1453 - 1460
[6] Peroral gene therapy of lactose intolerance using an adeno-associated virus vector
During, MJ
Xu, RL
Young, D
Kaplitt, MG
Sherwin, RS
Leone, P
[J]. NATURE MEDICINE, 1998, 4 (10) : 1131 - 1135
[7] Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse
Fong, LYY
Magee, PN
[J]. CANCER LETTERS, 1999, 143 (01) : 63 - 69
[8] Muir-Torre-like syndrome in Fhit-deficient mice
Fong, LYY
Fidanza, V
Zanesi, N
Lock, LF
Siracusa, LD
Mancini, R
Siprashvili, Z
Ottey, M
Martin, SE
Druck, T
McCue, PA
Croce, CM
Huebner, K
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (09) : 4742 - 4747
[9] Glover TW, 1998, CANCER RES, V58, P3409
[10] Novel tools for production and purification of recombinant adenoassociated virus vectors
Grimm, D
Kern, A
Rittner, K
Kleinschmidt, JA
[J]. HUMAN GENE THERAPY, 1998, 9 (18) : 2745 - 2760

← 1 2 3 4 →